← All candidates
2 insider filings on record.
3 filings on record.
TLSITriSalus Life Sciences, Inc.
NasdaqGM · Healthcare · $287.43M
$4.78
+0.21% · Sep 15
2 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$287.43M
Float
49.3M
80% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
6.4
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$8.80 avg target
+84.1% vs today · 5 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 3 quarters beat
Q4 '25−$0.05 act+$0.08
Q3 '25−$0.87 act−$0.70
Q2 '25−$0.23 act−$0.01
Coverage
TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...GuruFocus.com · 05-13TriSalus Life Sciences Q1 Earnings Call HighlightsMarketBeat · 05-13TriSalus Life Sciences, Inc. Q1 2026 Earnings Call SummaryMoby · 05-13TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue EstimatesZacks · 05-12
The file stays open
3 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice